DV
Dividend Vision

CERO — CERo Therapeutics Holdings, Inc. Common Stock

CERo Therapeutics Holdings, Inc. Common Stock (CERO)

Total return is -100.0% over the past 4.7 years, 181.8 points behind SPY at 81.8%. Its deepest 1-year drawdown was 99.9%.

CERO appears to be a single-stock holding rather than a diversified ETF, representing shares of CERo Therapeutics Holdings, Inc., a biotechnology or therapeutic company. As an individual equity position, it does not currently offer a dividend yield or regular distribution rate, which distinguishes it from income-focused ETFs. This holding may appeal primarily to growth-oriented investors seeking exposure to the therapeutic sector rather than those prioritizing dividend income.

CERO key facts

Asset type
Stock
Asset class
Equity
Inception date
11/30/2021
Last close
$0.01
Market cap
$496,236
Average volume
549900.0
Beta
0.162
Payout ratio
0.0
P/E ratio
0.0012
Forward P/E
0.0
EPS
$9.04